Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3

Letter to the Editor

Eculizumab para el tratamiento de un síndrome urémico hemolítico atípico con mutaciones en los factores I y C3 del sistema del complemento

Emanuel Ferreiraa,

Corresponding author

emanuelfeferreira@gmail.com

Corresponding author at: Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral., Rua do Buxo, lote 17, 3040-792 Coimbra, Portugal. Tel.: +351 916699039.

, Nuno Oliveiraa, Maria Marquesa, Luís Franciscob, Ana Santosa, Armando Carreiraa, Mário Camposc

a Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral, Coimbra, Portugal

b Servicio de Hematología, Centro Hospitalar e Universitário de Coimbra–Hospital Geral, Coimbra, Portugal

c Servicio de Nefrología, Centro Hospitalar e Universitário de Coimbra–Hospitais da Universidade de Coimbra, Coimbra, Portugal

Read

11721

Times
was read the article

2944

Total PDF

8777

Total HTML

Share statistics

Article information

ISSN: 02116995
Original language: English

DOI:10.1016/j.nefro.2015.07.007

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 May	61	20	81
2025 April	101	24	125
2025 March	133	51	184
2025 February	90	42	132
2025 January	95	30	125
2024 December	79	33	112
2024 November	88	68	156
2024 October	74	38	112
2024 September	74	36	110
2024 August	93	55	148
2024 July	55	26	81
2024 June	75	38	113
2024 May	81	31	112
2024 April	92	42	134
2024 March	67	30	97
2024 February	87	43	130
2024 January	63	25	88
2023 December	55	26	81
2023 November	65	35	100
2023 October	71	40	111
2023 September	47	33	80
2023 August	57	32	89
2023 July	66	26	92
2023 June	94	17	111
2023 May	93	30	123
2023 April	60	12	72
2023 March	101	27	128
2023 February	64	21	85
2023 January	70	27	97
2022 December	75	38	113
2022 November	57	37	94
2022 October	88	40	128
2022 September	64	36	100
2022 August	55	53	108
2022 July	54	54	108
2022 June	33	37	70
2022 May	61	49	110
2022 April	69	59	128
2022 March	67	44	111
2022 February	43	45	88
2022 January	42	36	78
2021 December	42	38	80
2021 November	38	42	80
2021 October	54	54	108
2021 September	35	32	67
2021 August	36	38	74
2021 July	44	38	82
2021 June	49	21	70
2021 May	57	34	91
2021 April	104	67	171
2021 March	84	34	118
2021 February	83	24	107
2021 January	58	30	88
2020 December	59	23	82
2020 November	41	24	65
2020 October	43	25	68
2020 September	46	31	77
2020 August	57	30	87
2020 July	55	9	64
2020 June	61	23	84
2020 May	66	20	86
2020 April	43	25	68
2020 March	41	19	60
2020 February	48	23	71
2020 January	60	24	84
2019 December	46	31	77
2019 November	57	37	94
2019 October	52	21	73
2019 September	51	18	69
2019 August	44	25	69
2019 July	46	26	72
2019 June	51	40	91
2019 May	44	31	75
2019 April	77	24	101
2019 March	58	24	82
2019 February	46	20	66
2019 January	52	20	72
2018 December	152	43	195
2018 November	223	20	243
2018 October	228	20	248
2018 September	92	15	107
2018 August	69	10	79
2018 July	64	11	75
2018 June	95	11	106
2018 May	112	10	122
2018 April	164	12	176
2018 March	124	12	136
2018 February	165	9	174
2018 January	82	7	89
2017 December	143	14	157
2017 November	83	13	96
2017 October	52	6	58
2017 September	43	14	57
2017 August	56	11	67
2017 July	56	19	75
2017 June	50	24	74
2017 May	62	19	81
2017 April	45	7	52
2017 March	38	27	65
2017 February	42	11	53
2017 January	36	6	42
2016 December	56	11	67
2016 November	79	15	94
2016 October	102	20	122
2016 September	127	8	135
2016 August	132	1	133
2016 July	194	7	201
2016 June	121	0	121
2016 May	162	0	162
2016 April	136	0	136
2016 March	156	0	156
2016 February	183	0	183
2016 January	54	0	54
2015 December	38	0	38
2015 November	74	0	74

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter